APA (7th ed.) Citation

A, A., V, C., M, E., V, L., & G, V. (2025). Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: A network meta-analysis. European heart journal open, 5(6), oeaf147. https://doi.org/10.1093/ehjopen/oeaf147

Chicago Style (17th ed.) Citation

A, Aimo, Castiglione V, Emdin M, Lorenzoni V, and Vergaro G. "Relative Efficacy of Tafamidis, Acoramidis, Patisiran and Vutrisiran in Patients with Transthyretin Cardiac Amyloidosis: A Network Meta-analysis." European Heart Journal Open 5, no. 6 (2025): oeaf147. https://doi.org/10.1093/ehjopen/oeaf147.

MLA (9th ed.) Citation

A, Aimo, et al. "Relative Efficacy of Tafamidis, Acoramidis, Patisiran and Vutrisiran in Patients with Transthyretin Cardiac Amyloidosis: A Network Meta-analysis." European Heart Journal Open, vol. 5, no. 6, 2025, p. oeaf147, https://doi.org/10.1093/ehjopen/oeaf147.